SEATTLE–(BUSINESS WIRE)–#EnteralFeeding–According to Coherent Market Insights, the global enteral feeding devices market is estimated to be valued at US$ 3,260.6 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2020-2027).
Key Trends and Analysis of the Global Enteral Feeding Devices Market:
Key trends in the market include increasing incidences of chronic and life threatening diseases such as diabetes, cancer, cardiovascular diseases and other, increasing launch of novel product and increasing collaborations and acquisitions among key players. These are expected to aid in growth of the market.
According to the report published by The International Diabetes Federation (IDF) in February 2020, in 2019, around 463 million adults (20-79 years) were living with diabetes around the world and it is expected to rise to 700 million by 2045 globally. Moreover, according to the same source, diabetes caused 4.2 million deaths globally in 2019 and 79% of adults with diabetes were living in low- and middle-income countries.
Moreover, increasing launch of novel products is expected to drive the market growth over the forecast period. For instance, In June 2020, Applied Medical Technology, Inc. (AMT), a enteral feeding devices and surgical products manufacturing company launched its new mobile app, AMT ONE Source.
Request for Sample Pages of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/392
Furthermore, key players operating in the global enteral feeding devices market are focusing on adoption of inorganic growth strategies such as acquisitions and collaborations in order to increase their market presence in the global market. For instance, in July 2017, Cardinal Health, Inc., a medical devices company completed the acquisition of Medtronic’s Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses for US$ 6.1 billion, including numerous industry-leading brands such as Curity, Kendall, Dover, Argyle and Kangaroo – brands used in nearly every U.S. hospital.
Key Market Takeaways:
The global enteral feeding devices market is expected to exhibit a CAGR of 5.8% over the forecast period. This is owing to increasing incidences of cardiovascular diseases. For instance, according to the World Health Organization 2017 report, an estimated 17.9 million people died due to cardiovascular diseases (CVDs) in 2016, representing 31% of all global deaths, out of which, around 85% deaths are caused due to heart attack and stroke.
Among product type, feeding tubes segment accounted for the largest market share in 2020, owing to increasing number of central nervous system and mental health disorders which is expected to increase demand for feeding tubes. According to a recently published research 2019, neurological disorder is the second leading cause of approximately 9 million deaths, worldwide.
Competitive Landscape:
Key players operating in the global enteral feeding devices market include Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Amsino International Inc., Applied Medical Technology, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Moog, Inc., Vygon S.A, Dynarex Corporation, and Medela AG.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/392
Market Segmentation:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
Contacts
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter
Parenting is a hard job under the best of circumstances. It can be especially confusing…
HUNTSVILLE, AL / ACCESSWIRE / June 19, 2024 / Curiteva, Inc., a leading technology and…
TORONTO, ON / ACCESSWIRE / June 19, 2024 / Theralase® Technologies Inc. ("Theralase®" or the…
ATLANTA, June 19, 2024 (GLOBE NEWSWIRE) -- Sharecare (NASDAQ: SHCR), the digital health company that…
Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people…
LOS ANGELES, June 19, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the…